AAAAAA
Results: 1-25/63
Authors:
Dekeyne, A
Gobert, A
Iob, L
Cistarelli, L
Melon, C
Millan, MJ
Citation: A. Dekeyne et al., Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats, PSYCHOPHAR, 158(2), 2001, pp. 213-218
Authors:
Millan, MJ
Newman-Tancredi, A
Quentric, Y
Cussac, D
Citation: Mj. Millan et al., The '' selective '' dopamine D-1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin(2C) receptors, PSYCHOPHAR, 156(1), 2001, pp. 58-62
Authors:
Dekeyne, A
Iob, L
Millan, MJ
Citation: A. Dekeyne et al., Following long-term training with citalopram, both mirtazapine and mianserin block its discriminative stimulus properties in rats, PSYCHOPHAR, 153(3), 2001, pp. 389-392
Authors:
Millan, MJ
Brocco, M
Gobert, A
Dorey, G
Casara, P
Dekeyne, A
Citation: Mj. Millan et al., Anxiolytic properties of the selective, non-peptidergic CRF1 antagonists, CP154,526 and DMP695: A comparison to other classes of anxiolytic agent, NEUROPSYCH, 25(4), 2001, pp. 585-600
Authors:
Audinot, V
Newman-Tancredi, A
Cussac, D
Millan, MJ
Citation: V. Audinot et al., Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT1D receptors, NEUROPSYCH, 25(3), 2001, pp. 410-422
Authors:
Dekeyne, A
Rivet, JM
Gobert, A
Millan, MJ
Citation: A. Dekeyne et al., Generalization of serotonin (5-HT)(1A) agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminativestimuli elicited by PD128,907 and 7-OH-DPAT, NEUROPHARM, 40(7), 2001, pp. 899-910
Authors:
Milligan, G
Kellett, E
Dacquet, C
Dubreuil, V
Jacoby, E
Millan, MJ
Lavielle, G
Spedding, M
Citation: G. Milligan et al., S 14506: novel receptor coupling at 5-HT1A receptors, NEUROPHARM, 40(3), 2001, pp. 334-344
Authors:
Audinot, V
Newman-Tancredi, A
Millan, MJ
Citation: V. Audinot et al., Constitutive activity at serotonin 5-HT1D receptors: detection by homologous GTP gamma S versus [S-35]-GTP gamma S binding isotherms, NEUROPHARM, 40(1), 2001, pp. 57-64
Authors:
Newman-Tancredi, A
Chaput, C
Touzard, M
Millan, MJ
Citation: A. Newman-tancredi et al., Pindolol antagonises G-protein activation at both pre- and postsynaptic serotonin 5-HT1A receptors: a [S-35]GTP gamma S autoradiography study, N-S ARCH PH, 363(4), 2001, pp. 391-398
Authors:
Millan, MJ
Gobert, A
Lejeune, F
Newman-Tancredi, A
Rivet, JM
Auclair, A
Peglion, JL
Citation: Mj. Millan et al., S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine, J PHARM EXP, 298(2), 2001, pp. 565-580
Authors:
Millan, MJ
Dekeyne, A
Papp, M
La Rochelle, CD
Macsweeny, C
Peglion, JL
Brocco, M
Citation: Mj. Millan et al., S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine, J PHARM EXP, 298(2), 2001, pp. 581-591
Authors:
Millan, MJ
Cussac, D
Milligan, G
Carr, C
Audinot, V
Gobert, A
Lejeune, F
Rivet, JM
Brocco, M
Duqueyroix, D
Nicolas, JP
Boutin, JA
Newman-Tancredi, A
Citation: Mj. Millan et al., Antiparkinsonian agent piribedil displays antagonist properties at native,rat, and cloned, human alpha(2)-adrenoceptors: Cellular and functional characterization, J PHARM EXP, 297(3), 2001, pp. 876-887
Authors:
Millan, MJ
Lejeune, F
De Nanteuil, G
Gobert, A
Citation: Mj. Millan et al., Selective blockade of neurokinin (NK)(1) receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in rats, J NEUROCHEM, 76(6), 2001, pp. 1949-1954
Authors:
Cordi, AA
Berque-Bestel, I
Persigand, T
Lacoste, JM
Newman-Tancredi, A
Audinot, V
Millan, MJ
Citation: Aa. Cordi et al., Potential antidepressants displayed combined alpha(2)-adrenoceptor antagonist and monoamine uptake inhibitor properties, J MED CHEM, 44(5), 2001, pp. 787-805
Authors:
Newman-Tancredi, A
Verriele, L
Touzard, M
Millan, MJ
Citation: A. Newman-tancredi et al., Efficacy of antipsychotic agents at human 5-HT1A receptors determined by [H-3]WAY100,635 binding affinity ratios: Relationship to efficacy for G-protein activation, EUR J PHARM, 428(2), 2001, pp. 177-184
Authors:
Millan, MJ
Newman-Tancredi, A
Duqueyroix, D
Cussac, D
Citation: Mj. Millan et al., Agonist properties of pindolol at h5-HT1A receptors coupled to mitogen-activated protein kinase, EUR J PHARM, 424(1), 2001, pp. 13-17
Authors:
Newman-Tancredi, A
Verriele, L
Millan, MJ
Citation: A. Newman-tancredi et al., Differential modulation by GTP gamma S of agonist and inverse agonist binding to h5-HT1A receptors revealed by [H-3]-WAY100,635, BR J PHARM, 132(2), 2001, pp. 518-524
Authors:
Dekeyne, A
Brocco, M
Adhumeau, A
Gobert, A
Millan, MJ
Citation: A. Dekeyne et al., The selective serotonin (5-HT)(1A) receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats - A comparison with other anxiolytic agents, PSYCHOPHAR, 152(1), 2000, pp. 55-66
Authors:
Yang, DL
Kefi, S
Audinot, V
Millan, MJ
Langlois, M
Citation: Dl. Yang et al., Benzamides derived from 1,2-diaminocyclopropane as novel ligands for humanD-2 and D-3 dopamine receptors, BIO MED CH, 8(2), 2000, pp. 321-327
Authors:
Lejeune, F
Millan, MJ
Citation: F. Lejeune et Mj. Millan, Pindolol excites dopaminergic and adrenergic neurons, and inhibits serotonergic neurons, by activation of 5-HT1A receptors, EUR J NEURO, 12(9), 2000, pp. 3265-3275
Authors:
Millan, MJ
Gobert, A
Rivet, JM
Adhumeau-Auclair, A
Cussac, D
Newman-Tancredi, A
Dekeyne, A
Nicolas, JP
Lejeune, F
Citation: Mj. Millan et al., Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha(2)-adrenergic and serotonin(2C) receptors: a comparison with citalopram, EUR J NEURO, 12(3), 2000, pp. 1079-1095
Authors:
Gobert, A
Rivet, JM
Lejeune, F
Newman-Tancredi, A
Adhumeau-Auclair, A
Nicolas, JP
Cistarelli, L
Melon, C
Millan, MJ
Citation: A. Gobert et al., Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat, SYNAPSE, 36(3), 2000, pp. 205-221
Authors:
Millan, MJ
Newman-Tancredi, A
Audinot, V
Cussac, D
Lejeune, F
Nicolas, JP
Coge, F
Galizzi, JP
Boutin, JA
Rivet, JM
Dekeyne, A
Gobert, A
Citation: Mj. Millan et al., Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT1B, 5-HT1D and dopamine D-2 and D-3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states, SYNAPSE, 35(2), 2000, pp. 79-95
Authors:
Morris, BJ
Newman-Tancredi, A
Audinot, V
Simpson, CS
Millan, MJ
Citation: Bj. Morris et al., Activation of dopamine D-3 receptors induces c-fos expression in primary cultures of rat striatal neurons, J NEUROSC R, 59(6), 2000, pp. 740-749
Authors:
Millan, MJ
Lejeune, F
Gobert, A
Citation: Mj. Millan et al., Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents, J PSYCHOPH, 14(2), 2000, pp. 114-138